BIONTECH SE - AMERICAN DEPOSITARY SHARES

BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update

07 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

04 Nov 2022 06:48:48 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age

12 Oct 2022 10:30:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

25 Jun 2022 10:02:16 By Nasdaq GlobeNewswire

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

15 Mar 2022 18:00:00 By Nasdaq GlobeNewswire

BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC

08 Mar 2022 08:27:07 By Nasdaq GlobeNewswire

BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer

21 Feb 2022 13:25:00 By Nasdaq GlobeNewswire

BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa

16 Feb 2022 05:30:00 By Nasdaq GlobeNewswire

BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide an Update on Sustainable Vaccine Manufacturing in Africa

15 Feb 2022 09:40:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request from U.S. FDA

01 Feb 2022 16:27:49 By Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age

25 Jan 2022 06:45:00 By Nasdaq GlobeNewswire

BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants

11 Jan 2022 07:00:00 By Nasdaq GlobeNewswire

BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies

10 Jan 2022 08:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine

05 Jan 2022 06:45:00 By Nasdaq GlobeNewswire

BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference

27 Dec 2021 06:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older

09 Dec 2021 12:15:00 By Nasdaq GlobeNewswire

BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant

08 Dec 2021 07:15:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Provide Update on Omicron Variant

08 Dec 2021 06:56:44 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union

25 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age

22 Nov 2021 06:45:00 By Nasdaq GlobeNewswire